Media Coverage header image

Media Coverage

Advanced Search
  • 05292023
    The Pathologist

    Dr. Mark Kruzel, MD, MBA, Associate Medical Director of Oncology at Quest Diagnostics, shares how the pathology-oncology care team can work together more closely to leverage the true power of precision therapies.

  • 05182023
    CBS News

    As the number of cannabis-friendly states across the U.S. has grown, so, too, has the drug's usage among American workers. An annual analysis from Quest Diagnostics medical lab and testing company shows the percentage of general U.S. employees, who tested positive for cannabis in 2022 reached the highest level ever recorded by Quest, which began analyzing annual workplace drug testing data in 1988.

  • 05182023
    The Wall Street Journal

    As legal marijuana expands in the U.S., a record share of workers is testing positive for the substance in workplace drug screening. Overall drug use among workers tested by employers generally held steady last year, according to an annual tally from Quest Diagnostics, one of the country’s largest drug-testing laboratories. In drug tests given to workers after accidents on the job, marijuana positives rose sharply last year, hitting the highest level in a quarter-century.

  • 05122023
    Clinical Lab Products

    Quest Diagnostics announced nationwide availability of the RestoreU Dementia Panel, a risk assessment and care plan AI-powered test service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline.

  • 05112023
    USA Today

    Thursday marks the end of the public health emergency in the United States, more than three years after it was first declared to combat the novel coronavirus by unlocking powerful tools to detect and contain the emerging threat. While it closes a chapter in history, health experts point out the COVID-19 pandemic is not yet over as the virus continues to claim about 1,000 lives each week, according to the Centers for Disease Control and Prevention. Quest Diagnostics, one of the largest lab companies in the country, said labs will continue to provide COVID-19 services and tests, but “access to, fees and reimbursement for COVID-19 testing will change after the (public health emergency) expires.”

  • 05082023
    Fox News

    With so many different factors — genetics, lifestyle and environment — influencing a person’s risk of developing Alzheimer’s, many doctors are moving away from one-size-fits-all approaches and calling for more individualized treatments. It’s a concept known as precision medicine. And it’s what inspired a company called uMETHOD to create RestoreU, a tool that uses artificial intelligence to help physicians create personalized care plans for patients with Alzheimer’s and other types of dementia. "Dementia is what’s called a complex disease," CEO Vik Chandra, co-founder and CEO of uMETHOD Health in Cary, North Carolina, said in an interview with Fox News Digital. Through a partnership with Quest Diagnostics, uMETHOD has rolled out its AI service to physicians, who can order the service through the patient’s electronic health record. Once the physician orders the service, it triggers the exchange of extensive information between the doctor's electronic health record systems and Quest Diagnostics, Chandra explained.

  • 04272023
    Fierce Biotech

    Quest Diagnostics is hoping it’s found a winner in Haystack Oncology, with a $450 million bet on the cancer-focused blood test startup. The clinical testing giant plans to acquire Baltimore-based Haystack for its technology to detect minimal residual disease by catching the early signs of a solid tumor’s recurrence by sifting out small pieces of cancer DNA floating in the bloodstream.

  • 04272023
    Reuters

    Quest Diagnostics Inc posted first-quarter profit ahead of Wall Street estimates on Thursday as its base business helped offset a fall in COVID-19 test kits sales. Demand for routine diagnostic tests has picked up as an increasing number of people return to the healthcare system for routine care after delaying care during the pandemic.

  • 04202023
    Managed Healthcare Executive

    For health plans to try to tackle the complex issue of food insecurity and its overall impact and consequences, it takes another step, but the outcomes are worth it. Let’s look at Pack Health’s Better Food for Better Health (BFBH) to demonstrate. Our food insecurity solution combines biweekly food box delivery, food security screenings and digital health coaching into an in-depth, but practical, program for those experiencing food insecurity. BFBH presents a valuable opportunity for health plans, health systems, and employers to support vulnerable populations experiencing food insecurity.

  • 04172023

    Secaucus-based Quest Diagnostics and NewYork-Presbyterian on Monday announced that Quest has completed its previously announced acquisition of select assets of the laboratory services business of NewYork-Presbyterian. Financial details of the transaction were not disclosed.

  • 04122023
    Newsweek

    Because trust plays a big part in customers' decisions about what to buy, employees' decisions about where to work and investors decisions about whether to invest, Newsweek, in collaboration with market research partner Statista, is proud to introduce our second annual listing of the Most Trustworthy Companies in America. This year we've listed 700 U.S. companies in 23 industries according to their evaluations by U.S. customers, employees and investors.

    11: Health Care & Life Sciences / Quest Diagnostics / New Jersey / Public Company

  • 04042023
    FierceHealthcare

    Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among patients by making the testing more accessible. Its Advanced Specialized Transplant Services now include customized educational resources for patients, expedited transport and processing of tests and 5,000 mobile phlebotomists for at-home specimen collection.

  • 03272023
    NJBIZ

    Times like these demonstrate the importance of the health care industry to New Jersey’s economy. The sector’s impact has been well documented in dollar terms over the years and officials at levels profess to recognize the critical role health care companies play – not only in providing care but also keeping the state in business. This year’s Health Care Power 50 list reflects another side of the economic story.

  • 03232023
    ROI-NJ

    Quest Diagnostics on Wednesday announced support for a new program with Sesame Workshop, the nonprofit educational organization behind “Sesame Street.” The resources launched aim to address health and well-being inequities among young children, particularly in low-income, rural and marginalized communities.

  • 03222023
    Lab Pulse

    Quest Diagnostics has introduced two Post-COVID-19 panels for consumers that offer information about lingering health issues associated with previous COVID-19 virus infections.

  • 03162023
    Science

    Doctors and drug companies are also warming to the medical possibilities of ceramides. Later this year, lab testing giant Quest Diagnostics will start to offer the analysis, potentially making it available to many more patients.

  • 03132023
    Health News

    Diagnosing Alzheimer’s disease before symptoms develop may soon be as simple as getting a blood test. New blood tests for certain biomarkers show promise, providing physicians an alternative to expensive scans or invasive spinal taps to make a diagnosis. Quest AD-Detect: Introduced by Quest Diagnostics, this blood test also measures beta-amyloid proteins in your blood to determine your risk for developing Alzheimer’s disease. It does not determine if you have any genetic biomarkers for the disease. The test became available in May 2022, with a cost of $500. There is limited coverage by some health plans.

  • 03062023
    NJBIZ

    Although automation and artificial intelligence have long been recognized as a way to improve operational efficiency in clinical laboratories, an industry-wide staffing shortage is creating an added motivation to incorporate more technology. At Secaucus-based Quest Diagnostics, it’s just one of many market forces that is shaping the company’s post-pandemic business strategy.

  • 03012023
    Fortune

    Medical testing center operator Quest Diagnostics Inc. said that it has begun using a highly automated microbiology lab system that leverages AI to analyze samples. CEO Jim Davis mentioned the platform in the company’s earnings call when he was talking about ways in which it’s trying to counter “significant inflation and wage pressures.”

  • 02212023
    AARP

    Do you know your blood type? There’s a good chance that you don’t. More Americans know their horoscope sign (66 percent) than their blood type (51 percent), according to a survey published this year by laboratory company Quest.

  • 02142023
    Crain's New York

    Quest Diagnostics, a nationwide medical testing company, will acquire some lab services from New York-Presbyterian in the coming months, the organizations announced Tuesday. The deal will allow physicians affiliated with New York-Presbyterian who work outside of the hospital to send diagnostics for processing to Quest’s laboratory in Clifton, New Jersey. The organizations said they expect to complete the deal in the second quarter of this year, pending regulatory approvals. This acquisition will not affect all testing services. New York-Presbyterian will keep anatomical pathology testing in house along with other diagnostics that require a quick turnaround time, the organizations said.

  • 02022023
    Becker's Hospital Review

    While tech companies Apple, Amazon and Microsoft took top spots on the 2023 "World's Most Admired Companies" list released by Fortune on Feb. 1, healthcare-related companies were also included. The list, a partnership between Fortune and global management consulting firm Korn Ferry, is based on an analysis of 645 companies in 27 countries. 34 healthcare companies are among the Most Admired Companies in their industries.

  • 01252023
    WABI-TV/CBS

    EJ Hikel from Northern Light Health and Brandy Dow from Quest Diagnostics talk about blood donation.

  • 01232023
    Medical Laboratory Observer

    Ten years ago, drug overdoses claimed nearly 42,000 lives annually in the United States. By the end of 2021, that number climbed to nearly 108,000. Today, the drug crisis shows no signs of abating, and remains largely fueled by increased access to illicit drugs as well as barriers to healthcare access exacerbated by the COVID-19 pandemic. For the last decade, Quest Diagnostics, through its Health Trends program, has examined insights gleaned from results of our large volume of clinical drug tests, with a goal of empowering better patient care, population health management and informing public health policy.

  • 01232023
    NJBIZ

    Anyone who has had medical tests performed likely knows about Quest Diagnostics. The Secaucus-based company is perhaps the most prominent testing company in the world. For this edition of NJBIZ Conversations, Wendi Mader – Quest’s vice president of the commercial employer channel – talks about what it was like to play that role and discusses how she and her staff continue to help businesses identify and mitigate health risks faced by their employees.

Show 5102550100 per page